BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30356287)

  • 21. Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.
    Huerga H; Van Cutsem G; Ben Farhat J; Puren A; Bouhenia M; Wiesner L; Dlamini L; Maman D; Ellman T; Etard JF
    BMC Public Health; 2018 Mar; 18(1):303. PubMed ID: 29499668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High HIV-1 RNA Among Newly Diagnosed People in Botswana.
    Novitsky V; Prague M; Moyo S; Gaolathe T; Mmalane M; Yankinda EK; Chakalisa U; Lebelonyane R; Khan N; Powis KM; Widenfelt E; Gaseitsiwe S; Dryden-Peterson SL; Holme MP; De Gruttola V; Bachanas P; Makhema J; Lockman S; Essex M
    AIDS Res Hum Retroviruses; 2018 Mar; 34(3):300-306. PubMed ID: 29214845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
    Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cascade of HIV care and population viral suppression in a high-burden region of Kenya.
    Maman D; Zeh C; Mukui I; Kirubi B; Masson S; Opolo V; Szumilin E; Riche B; Etard JF
    AIDS; 2015 Jul; 29(12):1557-65. PubMed ID: 26244395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of a Modified In-House HIV-1 Avidity Assay among a Cohort of Newly Diagnosed HIV-1 Infected Individuals and the Effect of ART on the Maturation of HIV-1 Specific Antibodies.
    Alex D; Raj Williams TI; Sachithanandham J; Prasannakumar S; Demosthenes JP; Ramalingam VV; Victor PJ; Rupali P; Fletcher GJ; Kannangai R
    Curr HIV Res; 2019; 17(2):134-145. PubMed ID: 31309891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa.
    Petersen M; Balzer L; Kwarsiima D; Sang N; Chamie G; Ayieko J; Kabami J; Owaraganise A; Liegler T; Mwangwa F; Kadede K; Jain V; Plenty A; Brown L; Lavoy G; Schwab J; Black D; van der Laan M; Bukusi EA; Cohen CR; Clark TD; Charlebois E; Kamya M; Havlir D
    JAMA; 2017 Jun; 317(21):2196-2206. PubMed ID: 28586888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana.
    Novitsky V; Gaolathe T; Mmalane M; Moyo S; Chakalisa U; Yankinda EK; Marukutira T; Holme MP; Sekoto T; Gaseitsiwe S; Musonda R; van Widenfelt E; Powis KM; Khan N; Dryden-Peterson S; Bennett K; Wirth KE; Tchetgen ET; Bachanas P; Mills LA; Lebelonyane R; El-Halabi S; Makhema J; Lockman S; Essex M
    J Acquir Immune Defic Syndr; 2018 Aug; 78(5):557-565. PubMed ID: 29771781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migration in Namibia and its association with HIV acquisition and treatment outcomes.
    Low A; Sachathep K; Rutherford G; Nitschke AM; Wolkon A; Banda K; Miller LA; Solmo C; Jackson K; Patel H; McCracken S; Findley S; Mutenda N
    PLoS One; 2021; 16(9):e0256865. PubMed ID: 34473757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment.
    Grant-McAuley W; Laeyendecker O; Monaco D; Chen A; Hudelson SE; Klock E; Brookmeyer R; Morrison D; Piwowar-Manning E; Morrison CS; Hayes R; Ayles H; Bock P; Kosloff B; Shanaube K; Mandla N; van Deventer A; Ruczinski I; Kammers K; Larman HB; Eshleman SH
    BMC Infect Dis; 2022 Nov; 22(1):838. PubMed ID: 36368950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach.
    Lebelonyane R; Bachanas P; Block L; Ussery F; Alwano MG; Marukutira T; El Halabi S; Roland M; Abrams W; Ussery G; Miller JA; Lockman S; Gaolathe T; Holme MP; Hader S; Mills LA; Wirth K; Bock N; Moore J
    PLoS One; 2021; 16(8):e0255227. PubMed ID: 34375343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection.
    Lynch BA; Patel EU; Courtney CR; Nanfack AJ; Bimela J; Wang X; Eid I; Quinn TC; Laeyendecker O; Nyambi PN; Duerr R; Redd AD
    AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1114-1116. PubMed ID: 28670965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.
    Serhir B; Hamel D; Doualla-Bell F; Routy JP; Beaulac SN; Legault M; Fauvel M; Tremblay C;
    PLoS One; 2016; 11(5):e0156023. PubMed ID: 27224023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.
    Klock E; Wilson E; Fernandez RE; Piwowar-Manning E; Moore A; Kosloff B; Bwalya J; Bell-Mandla N; James A; Ayles H; Bock P; Donnell D; Fidler S; Hayes R; Eshleman SH; Laeyendecker O;
    J Int AIDS Soc; 2021 Dec; 24(12):e25830. PubMed ID: 34897992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP).
    Marukutira T; Block L; Alwano MG; Behel S; Jarvis JN; Chakalisa U; Powis K; Novitsky V; Bapati W; Wang H; Ussery F; Lebelonyane R; Mills LA; Moore J; Bachanas P
    PLoS One; 2019; 14(8):e0221629. PubMed ID: 31465494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closer to 90-90-90. The cascade of care after 10 years of ART scale-up in rural Malawi: a population study.
    Maman D; Chilima B; Masiku C; Ayouba A; Masson S; Szumilin E; Peeters M; Ford N; Heinzelmann A; Riche B; Etard JF
    J Int AIDS Soc; 2016; 19(1):20673. PubMed ID: 26894388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
    Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
    PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana.
    Moyo S; Gaseitsiwe S; Zahralban-Steele M; Maruapula D; Nkhisang T; Mokaleng B; Mohammed T; Ditlhako TR; Bareng OT; Mokgethi TP; van Widenfelt E; Pretorius-Holme M; Mine MO; Raizes E; Yankinda EK; Wirth KE; Gaolathe T; Makhema JM; Lockman S; Essex M; Novitsky V
    AIDS; 2019 May; 33(6):1073-1082. PubMed ID: 30946161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts-Malawi, 2017-2018.
    Agyemang EA; Kim AA; Dobbs T; Zungu I; Payne D; Maher AD; Curran K; Kim E; Kwalira H; Limula H; Adhikari A; Welty S; Kandulu J; Nyirenda R; Auld AF; Rutherford GW; Parekh BS
    PLoS One; 2022; 17(2):e0262071. PubMed ID: 35148312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.